Huang Z, Wu S. Acceptance of disability, coping style, perceived social support and quality of life among patients with chronic lymphedema: a cross-sectional study. Support Care Cancer. 2022;30(5):4099–108.
McDuff SG, Mina AI, Brunelle CL, et al. Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys. 2019;103(1):62–70.
Yoshihara M, Shimono R, Tsuru S, et al. Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: a multi-institutional retrospective study. Eur J Surg Oncol. 2020;46(7):1334–8. https://doi.org/10.1016/j.ejso.2020.01.033.
Bar AdV, Cheville A, Solin LJ, Dutta P, Both S, Harris EE. Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2010;76(1):85–90. https://doi.org/10.1016/j.ijrobp.2009.01.024.
Gebruers N, Verbelen H, De Vrieze T, Coeck D, Tjalma W. Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review. Arch Phys Med Rehabil. 2015;96(6):1131–9. https://doi.org/10.1016/j.apmr.2015.01.014.
Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(8 Suppl):2191–200. https://doi.org/10.1002/cncr.27476.
McLaughlin SA, Stout NL, Schaverien MV. Avoiding the swell: advances in lymphedema prevention, detection, and management. Am Soc Clin Oncol Educ Book. 2020;40(40):1–10. https://doi.org/10.1200/EDBK_280471.
Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536–42. https://doi.org/10.1200/JCO.2007.14.4899.
Kwan ML, Darbinian J, Schmitz KH, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg. 2010;145(11):1055–63. https://doi.org/10.1001/archsurg.2010.231.
Article PubMed Central PubMed Google Scholar
Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116(22):5138–49. https://doi.org/10.1002/cncr.25458.
Norman SA, Localio AR, Kallan MJ, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev. 2010;19(11):2734–46. https://doi.org/10.1158/1055-9965.EPI-09-1245.
Article PubMed Central PubMed Google Scholar
Todo Y, Yamamoto R, Minobe S, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119(1):60–4. https://doi.org/10.1016/j.ygyno.2010.06.018.
Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30(30):3726–33. https://doi.org/10.1200/JCO.2012.41.8574.
Akita S, Mitsukawa N, Rikihisa N, et al. Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer. Plast Reconstr Surg. 2013;131(2):283–90. https://doi.org/10.1097/PRS.0b013e318277870f.
Article CAS PubMed Google Scholar
Beesley VL, Rowlands IJ, Hayes SC, et al. Incidence, risk factors and estimates of a woman’s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. Gynecol Oncol. 2015;136(1):87–93.
Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65(1):55–81. https://doi.org/10.3322/caac.21253.
Clinckaert A, Callens K, Cooreman A, et al. The prevalence of lower limb and genital lymphedema after prostate cancer treatment: a systematic review. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14225667.
Lin Y, Xu Y, Wang C, et al. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis. Breast Cancer. 2021;28(6):1261–72. https://doi.org/10.1007/s12282-021-01263-8.
Article CAS PubMed Google Scholar
Bona AF, Ferreira KR, Carvalho RBM, Thuler LCS, Bergmann A. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review. Int J Gynecol Cancer. 2020;30(11):1697–704. https://doi.org/10.1136/ijgc-2020-001682.
Kuruvilla AS, Krajewski A, Li X, et al. Risk factors associated with postmastectomy breast cancer lymphedema: a multicenter retrospective analysis. Ann Plast Surg. 2022;88(3 Suppl 3):S239–45. https://doi.org/10.1097/sap.0000000000003107.
Article CAS PubMed Google Scholar
Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer. 2011;19(6):853–7. https://doi.org/10.1007/s00520-011-1089-9.
Article PubMed Central PubMed Google Scholar
Rockson SG, Zhou X, Zhao L, et al. Exploring disease interrelationships in patients with lymphatic disorders: a single center retrospective experience. Clin Transl Med. 2022;12(4):e760.
Article CAS PubMed Central PubMed Google Scholar
Shahpar H, Atieh A, Maryam A, et al. Risk factors of lymph edema in breast cancer patients. Int J Breast Cancer. 2013. https://doi.org/10.1155/2013/641818.
Article PubMed Central PubMed Google Scholar
Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304(24):2699–705. https://doi.org/10.1001/jama.2010.1837.
Article CAS PubMed Google Scholar
World Health Organization. Operational framework for monitoring social determinants of health equity. 2024. https://www.who.int/publications/i/item/9789240088320#:~:text=Download,(4.1%20MB). Accessed 30 Mar 2024.
Centers for Disease Control and Prevention. About Social Determinants of Health (SDOH). https://www.cdc.gov/socialdeterminants/about.html. Accessed 15 Oct 2022.
Afshar N, English DR, Milne RL. Factors explaining socio-economic inequalities in cancer survival: a systematic review. Cancer Control. 2021;28:10732748211011956. https://doi.org/10.1177/10732748211011956.
Article PubMed Central PubMed Google Scholar
Gupta E, Mitchell CH, Ngo-Huang A, Manne R, Stout NL. Addressing social determinants of health to reduce disparities among individuals with cancer: insights for rehabilitation professionals. Curr Oncol Rep. 2023;25(6):659–69.
Badger TA, Segrin C, Crane TE, et al. Social determinants of health and symptom burden during cancer treatment. Nurs Res. 2023;72(2):103–13.
Brearley SG, Stamataki Z, Addington-Hall J, et al. The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs. 2011;15(3):204–12. https://doi.org/10.1016/j.ejon.2011.02.005.
Article CAS PubMed Google Scholar
Fettes L, Neo J, Ashford S, Higginson IJ, Maddocks M. Trajectories of disability in activities of daily living in advanced cancer or respiratory disease: a systematic review. Disabil Rehabil. 2022;44(10):1790–801.
Dean LT, Kumar A, Kim T, et al. Race or resource? BMI, race, and other social factors as risk factors for interlimb differences among overweight breast cancer survivors with lymphedema. J Obes. 2016;2016:8241710. https://doi.org/10.1155/2016/8241710.
留言 (0)